Navigation Links
Coke Sued for Fraudulent Claims on Obesity-Promoting 'VitaminWater'
Date:1/15/2009

vitamins + water + sugar + hype = soda - bubbles

WASHINGTON, Jan. 15 /PRNewswire-USNewswire/ -- The Coca-Cola Company has been served notice a class action lawsuit filed (http://cspinet.org/new/pdf/vitaminwater_filed_complaint.pdf)over what the Center for Science in the Public Interest (CSPI) says are deceptive and unsubstantiated claims on its VitaminWater line of beverages.

Coke markets VitaminWater as a healthful alternative to soda by labeling its several flavors with such health buzz words as "defense," "rescue," "energy," and "endurance." The company makes a wide range of dramatic claims, including that its drinks variously reduce the risk of chronic disease, reduce the risk of eye disease, promote healthy joints, and support optimal immune function.

In fact, according to CSPI nutritionists, the 33 grams of sugar in each bottle of VitaminWater do more to promote obesity, diabetes, and other health problems than the vitamins in the drinks do to perform the advertised benefits listed on the bottles.

CSPI's litigation department is serving as co-counsel in the suit, filed yesterday in United States District Court in the Northern District of California. The other law firms involved in the case are Reese Richman LLP and Whatley Drake & Kallas, LLC.

"When I bought VitaminWater, frankly I thought I was doing myself a favor health-wise," said the plaintiff, San Francisco, California, resident James Koh, who used to purchase and drink VitaminWater after working out at the gym. "I was attracted by the prospect of getting extra vitamins. But I had no idea that I was actually getting almost a Coke's worth of sugar and calories. There's no way I would have spent money on that, had I known."'/>"/>

SOURCE Center for Science in the Public Interest
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Merck to Pay More Than $650 Million to Resolve Claims of Fraudulent Price Reporting and Kickbacks
2. Antibacterial Soap Claims Just Dont Wash
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
5. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
6. Aon Corporation Study Finds Hospital Claims at New Lows
7. Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims
8. Governor Rendell Says Mcare Claims and Costs Are 50 Percent Lower Than in 2003
9. Goulets Life Lost to Untreatable Lung Disease That Claims as Many Lives as Breast Cancer Each Year
10. Congress Proclaims Support for Long Term Care Awareness Week; Recent Poll Shows Voters Want Long Term Care Included in Presidential Candidates Healthcare Proposals
11. CIC Partners Announces Investment in OmniSYS, the Market Leader in Providing Solutions to Pharmacy-Related Medical Benefit Claims
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Video 3A Plan for Long Term Care Before the Crisis Hits 47797 1Video 3A Plan for Long Term Care Before the Crisis Hits 47797 2Video 3A Plan for Long Term Care Before the Crisis Hits 47797 3Video 3A Plan for Long Term Care Before the Crisis Hits 47797 4Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3Stepping up minority recruiting 47791 1Stepping up minority recruiting 47791 2Stepping up minority recruiting 47791 3